UniProt ID | FABP5_HUMAN | |
---|---|---|
UniProt AC | Q01469 | |
Protein Name | Fatty acid-binding protein 5 | |
Gene Name | FABP5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 135 | |
Subcellular Localization | Cytoplasm . Nucleus . Cell junction, synapse . Cell junction, synapse, postsynaptic cell membrane, postsynaptic density . Secreted . Localizes primarily to the cytoplasm. Upon certain ligand binding, a conformation change exposes a nuclear localizati | |
Protein Description | Intracellular carrier for long-chain fatty acids and related active lipids, such as the endocannabinoid, that regulates the metabolism and actions of the ligands they bind. In addition to the cytosolic transport, selectively delivers specific fatty acids from the cytosol to the nucleus, wherein they activate nuclear receptors. [PubMed: 22170058 Delivers retinoic acid to the nuclear receptor peroxisome proliferator-activated receptor delta; which promotes proliferation and survival. May also serve as a synaptic carrier of endocannabinoid at central synapses and thus controls retrograde endocannabinoid signaling. Modulates inflammation by regulating PTGES induction via NF-kappa-B activation, and prostaglandin E2 (PGE2) biosynthesis during inflammation (By similarity May be involved in keratinocyte differentiation] | |
Protein Sequence | MATVQQLEGRWRLVDSKGFDEYMKELGVGIALRKMGAMAKPDCIITCDGKNLTIKTESTLKTTQFSCTLGEKFEETTADGRKTQTVCNFTDGALVQHQEWDGKESTITRKLKDGKLVVECVMNNVTCTRIYEKVE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATVQQLEG ------CCCCEEEEC | 19.24 | 19413330 | |
3 | Phosphorylation | -----MATVQQLEGR -----CCCCEEEECC | 19.97 | 23532336 | |
10 | Methylation | TVQQLEGRWRLVDSK CCEEEECCEEEECCC | 13.13 | - | |
16 | Phosphorylation | GRWRLVDSKGFDEYM CCEEEECCCCHHHHH | 27.48 | 25159151 | |
17 | Acetylation | RWRLVDSKGFDEYMK CEEEECCCCHHHHHH | 60.16 | 19608861 | |
17 | Ubiquitination | RWRLVDSKGFDEYMK CEEEECCCCHHHHHH | 60.16 | 21890473 | |
17 | Succinylation | RWRLVDSKGFDEYMK CEEEECCCCHHHHHH | 60.16 | 23954790 | |
17 | Malonylation | RWRLVDSKGFDEYMK CEEEECCCCHHHHHH | 60.16 | 32601280 | |
17 | 2-Hydroxyisobutyrylation | RWRLVDSKGFDEYMK CEEEECCCCHHHHHH | 60.16 | - | |
22 | Phosphorylation | DSKGFDEYMKELGVG CCCCHHHHHHHHCHH | 18.48 | - | |
24 | Methylation | KGFDEYMKELGVGIA CCHHHHHHHHCHHHH | 49.22 | - | |
24 | Ubiquitination | KGFDEYMKELGVGIA CCHHHHHHHHCHHHH | 49.22 | 21906983 | |
34 | Ubiquitination | GVGIALRKMGAMAKP CHHHHHHHCCCCCCC | 42.40 | - | |
35 | Sulfoxidation | VGIALRKMGAMAKPD HHHHHHHCCCCCCCC | 3.15 | 21406390 | |
40 | Ubiquitination | RKMGAMAKPDCIITC HHCCCCCCCCEEEEE | 28.44 | - | |
40 | Acetylation | RKMGAMAKPDCIITC HHCCCCCCCCEEEEE | 28.44 | 23749302 | |
46 | Phosphorylation | AKPDCIITCDGKNLT CCCCEEEEECCCEEE | 5.66 | - | |
50 | 2-Hydroxyisobutyrylation | CIITCDGKNLTIKTE EEEEECCCEEEEEEC | 35.22 | - | |
50 | Acetylation | CIITCDGKNLTIKTE EEEEECCCEEEEEEC | 35.22 | 25038526 | |
50 | Ubiquitination | CIITCDGKNLTIKTE EEEEECCCEEEEEEC | 35.22 | - | |
55 | Ubiquitination | DGKNLTIKTESTLKT CCCEEEEEECCCEEE | 40.79 | 19608861 | |
55 | Acetylation | DGKNLTIKTESTLKT CCCEEEEEECCCEEE | 40.79 | 19608861 | |
61 | Ubiquitination | IKTESTLKTTQFSCT EEECCCEEEEEEEEE | 50.00 | 21890473 | |
61 | Malonylation | IKTESTLKTTQFSCT EEECCCEEEEEEEEE | 50.00 | 26320211 | |
61 | Acetylation | IKTESTLKTTQFSCT EEECCCEEEEEEEEE | 50.00 | 23236377 | |
63 | Phosphorylation | TESTLKTTQFSCTLG ECCCEEEEEEEEECC | 26.48 | 23312004 | |
67 | S-nitrosylation | LKTTQFSCTLGEKFE EEEEEEEEECCCCEE | 3.72 | 2212679 | |
67 | S-palmitoylation | LKTTQFSCTLGEKFE EEEEEEEEECCCCEE | 3.72 | 29575903 | |
72 | Ubiquitination | FSCTLGEKFEETTAD EEEECCCCEEEECCC | 57.17 | - | |
72 | Acetylation | FSCTLGEKFEETTAD EEEECCCCEEEECCC | 57.17 | 23749302 | |
76 | Phosphorylation | LGEKFEETTADGRKT CCCCEEEECCCCCEE | 21.78 | 20068231 | |
82 | Ubiquitination | ETTADGRKTQTVCNF EECCCCCEEEEEEEC | 50.98 | 21906983 | |
103 | Ubiquitination | QHQEWDGKESTITRK EECEECCCCCEEEEE | 46.12 | - | |
103 | 2-Hydroxyisobutyrylation | QHQEWDGKESTITRK EECEECCCCCEEEEE | 46.12 | - | |
103 | Acetylation | QHQEWDGKESTITRK EECEECCCCCEEEEE | 46.12 | 25038526 | |
122 | Sulfoxidation | KLVVECVMNNVTCTR CEEEEEEECCCEEEE | 4.58 | 21406390 | |
131 | Phosphorylation | NVTCTRIYEKVE--- CCEEEEEEEECC--- | 13.35 | 10493790 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FABP5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FABP5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FABP5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ALDR_HUMAN | AKR1B1 | physical | 26344197 | |
ECI1_HUMAN | ECI1 | physical | 26344197 | |
FKB1A_HUMAN | FKBP1A | physical | 26344197 | |
FKB1B_HUMAN | FKBP1B | physical | 26344197 | |
GRB2_HUMAN | GRB2 | physical | 26344197 | |
CH10_HUMAN | HSPE1 | physical | 26344197 | |
PIN1_HUMAN | PIN1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 2-10, AND ACETYLATION AT ALA-2. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-131, AND MASSSPECTROMETRY. |